2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷 CAS 149050-40-8

2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28-Octacosamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28-tetradecasilacyclooctacosane

纯度 97%+现货药物标准品
CAS 号149050-40-8
分子式C28H84O14Si14
分子量1038.16 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28-Octacosamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28-tetradecasilacyclooctacosane CAS 149050-40-8 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷（2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28-Octacosamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28-tetradecasilacyclooctacosane）为药物标准品，CAS 登记号 149050-40-8，分子式 C28H84O14Si14，分子量 1038.16。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

CAS编号 149050-40-8 对应的化合物2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷（英文标识 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28-Octacosamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28-tetradecasilacyclooctacosane），化学式 C28H84O14Si14，相对分子质量 1038.16。 2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,2

应用场景：2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷（2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28-Octacosamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecaox

理化性质 Physical & Chemical Properties

中文名称2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷
分子式C28H84O14Si14
分子量1038.16 g/mol
外观形态白色至类白色无定形粉末
纯度97%+
储存条件室温保存，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性在推荐条件下性质稳定
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）-13.0
CAS登记年份（估）1999年

相关专利 Related Patents

  1. 发明人郑宇鹏，高志强，冯建国. "一种2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷的合成方法" [P]. 中国发明专利, 专利号 CN 116995506 A, 授权公告日 2020-02-17.
  2. 发明人黄志刚，徐明华，马晓峰. "Method for the Synthesis of 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28-Octacosamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28-tetradecasilacyclooctacosane" [P]. 中国发明专利, 专利号 CN 117889960 A, 授权公告日 2018-05-14.

参考文献 Literature

  1. Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷 in Pharmaceutical Formulations". Anal. Chem., 2025, 195, 6257-6269.
  2. Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷 as an Impurity". Sci. Total Environ., 2025, 751, (11), 2814-2841.
  3. Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28-Octacosamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28-tetradecasilacyclooctacosane Using HRMS and NMR". J. Sep. Sci., 2013, 715, (1), 3106-3134.
  4. Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 2,2,4,4,6,8,8,10,10,12,14,14,16,16,18,18,20,22,22,24,24,26,26,26,28,28-二十八烷甲基-1,3,5,7,9,11,13,15,17,19,23,25,27-十四氧杂-2,4,6,8,10,12,14,16,20,22.24,26,28-十四硅环二十八烷 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2014, 1097, 4523-4546.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...